High Molecular Weight Forms of Antithrombin III Complexes in Blood

Summary A double antibody competition radioimmunoassay was developed that allowed to detect specifically as little as 15 ng antithrombin III (AT III) per ml of the assayed material. In normal plasma examined by this assay, AT III concentration averaged 199 ± 21 μg/ml. Complexes of AT III with thrombin or factor X a crossreacted with free AT III in 87% and 95%, respectively. Molecular forms of AT III produced in plasma treated with coagulation enzymes, or in serum, were assessed by measuring immunoreactive AT III in fractions obtained by gel filtration chromatography on Sephadex G-200. AT III bound by thrombin in fibrinogen free-plasma ranged in molecular size from 160,000 to above 250,000. Similar aggregation occurred when monomeric complex of purified AT III and thrombin, of 90,000 Mr, was added to plasma. Presence of heparin intensified the degree of aggregation. In factor Xa-treated plasma AT III was converted into components with 160,000 Mr, or less. No complexes below 200,000 Mr were present in serum. They decreased in size to 160,000 Mr after affinity chromatography on heparin-Sepharose. These results indicated that blood represents a unique milieu conducive to aggregation of bound AT III. It appears, however, that AT III complexes present in blood may not only aggregate, but also associate with other serum proteins through unstable binding most likely caused by the enzyme component of the complex.

[1]  K. Bauer,et al.  Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex. , 1982, Blood.

[2]  E. Marciniak Differential role of fractionated heparin in antithrombin-III proteolysis. , 1982, Blood.

[3]  R. Colman,et al.  Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. , 1982, The Journal of clinical investigation.

[4]  E. Marciniak Thrombin‐induced Proteolysis of Human Antithrombin III: an Outstanding Contribution of Heparin , 1981, British journal of haematology.

[5]  L. S. Lam,et al.  In vivo behaviour of some antithrombin III-protease complexes. , 1979, British journal of experimental pathology.

[6]  I. Danishefsky,et al.  Conformational changes accompanying the binding of antithrombin III to thrombin. , 1979, Biochemistry.

[7]  K. Orre,et al.  The production of an inactive form of antithrombin through limited proteolysis by thrombin , 1979, FEBS letters.

[8]  K. Mann,et al.  Comparison of the inhibition of thrombin by three plasma protease inhibitors. , 1978, Biochemistry.

[9]  I. Björk,et al.  Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin. , 1977, Thrombosis research.

[10]  E. Marciniak Antithrombin III and Heparin Inactivation in Thrombin Involving Reactions , 1977, Thrombosis and Haemostasis.

[11]  D. Pepper,et al.  The Different Forms of Antithrombin III in Serum , 1977, Thrombosis and Haemostasis.

[12]  J. Fenton,et al.  Human thrombins. Production, evaluation, and properties of alpha-thrombin. , 1977, The Journal of biological chemistry.

[13]  M. Verstraete,et al.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration , 1977, European journal of clinical investigation.

[14]  C. Marks,et al.  Radiolabelled ATIII as a probe for the detection of activation of blood coagulation in vivo. , 1976, Thrombosis research.

[15]  B. Furie,et al.  Coagulant protein of Russell's viper venom. , 1976, Methods in enzymology.

[16]  E. Marciniak Adverse Effect of Heparin in Thrombin-Antithrombin III Interaction , 1975, Thrombosis and Haemostasis.

[17]  R. Machovich Mechanism of action of heparin through thrombin on blood coagulation. , 1975, Biochimica et biophysica acta.

[18]  E. Thaler,et al.  A Simple Two‐step Isolation Procedure for Human and Bovine Antithrombin II/III (Heparin Cofactor): a Comparison of Two Methods , 1975, British journal of haematology.

[19]  F. Putnam The plasma proteins: Structure, function, and genetic control , 1975 .

[20]  K. Ohlsson,et al.  Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. , 1974, Scandinavian journal of clinical and laboratory investigation.

[21]  B. Binder On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum. , 1973, Thrombosis et diathesis haemorrhagica.

[22]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[23]  K. Ohlsson Interactions in vitro and in vivo between dog trypsin and dog plasma protease inhibitors. , 1971, Scandinavian journal of clinical and laboratory investigation.

[24]  A. Mcfarlane,et al.  Catabolism of plasma-proteins. , 1963 .